Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 35
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary
Appendix A
Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Lecture Room
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington, D.C. 20418
January 26–27, 2004
Day 1
8:30–9:00
Continental Breakfast, Lecture Room
9:00–9:30
Welcome and Introduction to the Workshop
Louise Russell, Ph.D., Rutgers University, Workshop Chair
Martin Brown, Ph.D., National Cancer Institute, Workshop Co-Chair
Judith Wagner, Ph.D., IOM Staff Officer
PART I: COMPARING ECONOMIC MODELS OF CRC SCREENING
9:30–11:00
Overview of Five Leading Economic Models of CRC Screening
The “Harvard Model”: Karen Kuntz, Sc.D., Harvard University
The “Ladabaum Model”: Uri Ladabaum, M.D., University of California at San Francisco
The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University
The “Vanderbilt Model”: Reid Ness, M.D., Vanderbilt University
The “Vijan Model”: Sandeep Vijan, M.D., University of Michigan
11:00–11:15
Break
11:15–11:45
Results of a Pre-Workshop Comparative Modeling Exercise
Michael Pignone, M.D., University of North Carolina
11:45–12:45
Discussion
12:45–1:15
Lunch
PART II: CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING
1:15–2:30
Evidence on Compliance (Q&A follows presentations)
Current Evidence on Compliance
Sally Vernon, Ph.D., University of Texas at Houston
OCR for page 36
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary
Recent Follow-up and Compliance Patterns of Medicare Patients
Todd Anderson, M.S., Congressional Budget Office
The Relationship Between Compliance and Capacity
Laura Seeff, M.D., Centers for Disease Control
2:30–3:15
Recent Findings on Test Performance
Brian Mullhall, M.D., Walter Reed Army Hospital
Q&A follows presentation
3:15–3:30
Break
3:30–4:15
Measuring the Cost of Screening, Follow-up, and Surveillance in Cost-Effectiveness Models
Martin Brown, Ph.D. National Cancer Institute
Q&A follows presentation
4:15–5:00
Evidence on Effectiveness of Follow-up and Surveillance Strategies
Deborah Schrag, M.D., Memorial Sloan Kettering Cancer Center
Q&A follows presentation
Day 2
8:30–9:00
Defining Issues: A Reprise of First Day’s Findings
Martin Brown, Michael Pignone, and Judith Wagner
PART III: MODELING THE NATURAL HISTORY OF COLORECTAL CANCER
9:00–9:45
Recent Evidence on Natural History
T.R.Levin, M.D., Kaiser Permanente Division of Research
Q&A follows presentation
9:45–10:00
The NCI CISNET Project: An Overview of Goals, Methods, and Current Status
Eric Feuer, Ph.D., National Cancer Institute
10:00–10:15
Break
10:15–11:15
Discussion of Issues in Modeling Natural History
11:15–12:00
Modelers’ Forum: Next Steps, Unresolved Questions, Critical Information Needs
Marjolein van Ballegooijen, Karen Kuntz, Sandeep Vijan, Reid Ness, Uri Ladabaum and Coauthors
12:00–1:00
Discussion and Wrap-up
1:00
Adjourn
Representative terms from entire chapter:
cancer screening
